Perception of risk: the state of COX-2 selective inhibitors

Curr Rheumatol Rep. 2005 Jun;7(3):163-6. doi: 10.1007/s11926-996-0032-4.

Authors

Lee S Simon¹, Vibeke Strand

Affiliation

¹ Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis Street, Suite 5A, Boston, MA 02115, USA. lsimon@caregroup.harvard.edu

PMID: 15918989
DOI: 10.1007/s11926-996-0032-4

No abstract available

Publication types

Review

MeSH terms

Cyclooxygenase Inhibitors*
Humans
Risk Assessment

Substances

Cyclooxygenase Inhibitors